Literature DB >> 27694655

Looking Beyond FDA Warning Letters to Explore Unforeseen Trouble Spots in eDTCA: A Response to Recent Commentaries.

Hyosun Kim1.   

Abstract

Mesh：

Year:  2016        PMID： 27694655      PMCID： PMC5042593          DOI： 10.15171/ijhpm.2016.92

Source DB:  PubMed          Journal:  Int J Health Policy Manag        ISSN： 2322-5939


× No keyword cloud information.
  9 in total

1.  Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters.

Authors:  Hyosun Kim
Journal:  Int J Health Policy Manag       Date:  2015-08-25

2.  Direct-to-consumer advertising with interactive internet media: global regulation and public health issues.

Authors:  Bryan A Liang; Timothy Mackey
Journal:  JAMA       Date:  2011-02-23       Impact factor: 56.272

3.  The Conundrum of Online Prescription Drug Promotion Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".

Authors:  Isaac Wanasika
Journal:  Int J Health Policy Manag       Date:  2016-03-26

4.  Digital Direct-to-Consumer Advertising: A Perfect Storm of Rapid Evolution and Stagnant Regulation Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".

Authors:  Tim K Mackey
Journal:  Int J Health Policy Manag       Date:  2016-02-03

5.  Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: Teaching Drug Marketers How to Inform Better or Spin Better? Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".

Authors:  Evan Doran
Journal:  Int J Health Policy Manag       Date:  2016-02-21

6.  Still the Great Debate - "Fair Balance" in Direct-to-Consumer Prescription Drug Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".

Authors:  Brent L Rollins
Journal:  Int J Health Policy Manag       Date:  2016-02-10

7.  Considering the Future of Pharmaceutical Promotions in Social Media Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".

Authors:  Francesca Renee Dillman Carpentier
Journal:  Int J Health Policy Manag       Date:  2016-02-09

8.  Future Challenges and Opportunities in Online Prescription Drug Promotion Research Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".

Authors:  Brian G Southwell; Douglas J Rupert
Journal:  Int J Health Policy Manag       Date:  2016-01-16

9.  The Tip of the Iceberg of Misleading Online Advertising Comment on "Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters".

Authors:  Barbara Mintzes
Journal:  Int J Health Policy Manag       Date:  2016-02-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.